The FDA has established a hierarchy of susceptibility1 in descending order of resistance by which the FDA recognizes that bacterial spores and vegetative bacteria (such as MRSA) are more resistant to kill than lipid viruses (such as Coronaviruses).
Based on the hierarchy of susceptibility, VESTEX®’s ability to reduce retention of MRSA on the surface of the apparel would also apply to COVID-19.
COVID-19 is spread mainly via aerosolized droplets from an infected person’s cough or sneeze. VESTEX® repels fluids and significantly reduces the number of microorganisms that remain on the fabric.
While the FDA has not yet reviewed the ability of VESTEX® to reduce COVID-19, preliminary research has documented results equal to or better than the reduction of MRSA. This research is being assessed analytically and VESTEX® does intend to seek FDA clearance for specific claims relating to retention of Coronaviruses on VESTEX® fabrics.
Watch Video: Effectiveness of VESTEX® Microbial Protection1 CDC Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008. William A. Rutala, Ph.D., M.P.H.1,2, David J. Weber, M.D., M.P.H.1,2, and the Healthcare Infection Control Practices Advisory Committee (HICPAC)